Paul Tudor Jones Chroma Dex Corp. Transaction History

Tudor Investment Corp Et Al

  • $21.5 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$5.42 - $7.08 $1.15 Million - $1.5 Million
-212,250 Reduced 57.09%
159,548 $979,000
Q1 2025

May 15, 2025
BUY
$5.26 - $8.55 $811,249 - $1.32 Million
154,230 Added 70.89%
371,798 $2.57 Million
Q4 2024

Feb 14, 2025
BUY
$3.25 - $7.72 $707,096 - $1.68 Million
217,568 New
217,568 $1.16 Million

Others Institutions Holding CDXC

# of Institutions
175
Shares Held
30.9M
Call Options Held
121K
Put Options Held
55.6K
View Full List

About ChromaDex Corp.

CDXC Quotes by TradingView
  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $420M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email